Kliniska studier för Migrän i Illinois
6 studier för Migrän söker deltagare vid platser i Illinois.
Städer i Illinois
Officiell studietext (engelska)
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Chicago Headache Center & Research Institute, Chicago
- AMR-Baber Research Inc, Naperville
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 24 sep. 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Chicago Headache Center & Research Institute, Chicago
- AMR-Baber Research Inc, Naperville
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 24 sep. 2026 · NCT04649242Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Chicago Headache Center & Research Institute /ID# 248625, Chicago
- Ascension Saint Alexius /ID# 275261, Hoffman Estates
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 14 sep. 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Cedar Crosse Research Center, Chicago
- Chicago Headache Center & Research Institute, Chicago
- Healthcare Research Network II, LLC, Flossmoor
- och 1 fler
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 20 aug. 2026 · NCT07645924Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks
- Chicago Headache Center & Research Inst /ID# 272345, Naperville
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 10 feb. 2026 · NCT07310290Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines
- Advocate Christ Medical Center Emergency Department, Oak Lawn
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 22 jan. 2026 · NCT06904287Från ClinicalTrials.gov, data hämtad 4 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.